Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm
1. Kuehn Law investigates Amicus Therapeutics for potential fiduciary breaches. 2. Investigation addresses possible self-dealing by officers and directors. 3. Shareholders may seek damages and governance reforms through litigation. 4. Long-term shareholders are encouraged to participate and protect their rights.